PharmTech Poll Results: Outsourced or In-house?
View the results of our poll on what services companies who outsource usually decide to keep in-house.
The question:
If your company uses contract service providers and manufacturers, which function(s) do you typically keep in-house?
Your responses:
- Discovery research (1 response)
- Preclinical animal research
- ADME-tox work
- Formulation development (1 response)
- Process development (1 response)
- Clincial-scale manufacturing through Phase I
- Clinical-scale manufacturing through Phase II
- Clinical-scale manufacturing through Phase III
- Clinical trials
- Scale-up to commercial manufacturing (2 responses)
- Commercial-scale manufacturing (2 responses)
- Fill-finish
- Other
Do you have any comments on this poll, or would you like to submit your vote? Email us at [email protected].
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
